Ivan Oransky is editor-in-chief of The Transmitter, having previously served in editorial leadership roles at outlets including Medscape, Reuters Health and Scientific American. He is a distinguished journalist-in-residence at New York University’s Arthur L. Carter Journalism Institute, where he teaches medical journalism, and co-founder of Retraction Watch, which reports on scientific retractions.
Ivan Oransky
Editor-in-chief
The Transmitter
”Our goal for The Transmitter is ambitious but clear. We aspire to become an essential resource for neuroscientists at all career stages, and to help them stay current and build connections.
From this contributor
Journal retracts paper on plant beauty that cited autism study
By
Ivan Oransky
25 April 2022 | 2 min read
Education
- M.D., New York University
- B.A. in biology, Harvard University
Articles
- “Rooting out scientific misconduct” | Science
- “Retractions are increasing, but not enough” | Nature
- “Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trials” | BMJ Open
- “How bibliometrics and school rankings reward unreliable science” | The BMJ
- “How to stop the unknowing citation of retracted papers” | Anesthesiology
- “Institutional research misconduct reports need more credibility” | JAMA
- “Science corrects itself, right? A scandal at Stanford says it doesn’t” | Scientific American
- “Image manipulation in science is suddenly in the news. But these cases are hardly rare” | STAT
- “Retractions in medicine: the tip of the iceberg” | European Heart Journal | Oxford Academic
- “Three randomized controlled trials evaluating the impact of ‘spin’ in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit” | BMC Medicine
- “Reasonable versus unreasonable doubt” | American Scientist
Book chapters
- “Journals, peer review, and preprints,” in “A Tactical Guide to Science Journalism: Lessons From the Front Lines”
- “Retraction Watch: What we’ve learned and how metrics play a role,” in “Gaming the Metrics: Misconduct and Manipulation in Academic Research”
- “Pseudoscience, coming to a peer-reviewed journal near you,” in “Pseudoscience: The Conspiracy Against Science”
- “Will improvements in health journalism improve health literacy?” in “Volume 269: Health Literacy in Clinical Practice and Public Health”
Explore more from The Transmitter
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
By
Carina Heller
20 January 2025 | 7 min read
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
Cracking the code of the extracellular matrix
Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.
By
Anna Victoria Molofsky
17 January 2025 | 5 min read
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
By
Angie Voyles Askham
16 January 2025 | 6 min read